background
studi
evalu
contribut
virus
bacteria
acut
exacerb
chronic
obstruct
pulmonari
diseas
aecopd
object
studi
estim
burden
type
pathogen
among
adult
seek
care
aecopd
two
consecut
winter
season
studi
design
patient
year
older
consult
within
day
aecopd
onset
elig
clinic
data
collect
standard
questionnair
nasopharyng
aspir
npa
pair
sera
noninduc
sputum
collect
polymeras
chain
reaction
prc
assay
use
identifi
viral
atyp
bacteri
pathogen
npa
specimen
result
overal
patient
aecopd
includ
patient
admit
patient
receiv
intens
care
third
patient
evid
viral
infect
influenza
rsv
one
patient
posit
mycoplasma
pneumonia
bacteri
pathogen
identifi
patient
avail
sputum
frequent
staphylococcu
aureu
pseudomona
aeruginosa
haemophilu
influenza
among
virusinfect
patient
also
bacteria
sputum
coinfect
patient
present
differ
symptom
patient
singl
infect
conclus
result
suggest
influenza
rsv
frequent
contributor
aecopd
coinfect
bacteria
appear
sever
among
virusinfect
patient
clinician
awar
aecopd
may
frequent
trigger
virus
may
consid
antivir
proper
infect
control
measur
appropri
epidemiolog
set
acut
exacerb
chronic
obstruct
pulmonari
diseas
aecopd
often
trigger
bacteri
viral
infect
airway
bacteria
implic
develop
aecopd
pathophysiolog
relationship
fulli
understood
believ
colon
promot
inflammatori
respons
subsequ
airway
obstruct
infect
may
directli
contribut
develop
aecopd
bacteria
isol
aecopd
ture
suggest
bacteria
may
sometim
innoc
bystand
rather
actual
caus
aecopd
addit
bacteria
recent
studi
use
sensit
nucleic
acid
detect
method
shown
respiratori
virus
may
frequent
trigger
aecopd
viral
infect
believ
respons
proport
aecopd
bacteri
infect
viral
infect
also
detect
stabl
copd
patient
suggest
virus
may
caus
persist
lowgrad
infect
could
contribut
pathogenesi
diseas
influenza
appear
frequent
detect
viru
condit
respiratori
syncyti
viru
rsv
also
lead
caus
virusinduc
exacerb
lower
respiratori
tract
infect
becom
frequent
recogn
purpos
studi
estim
burden
viral
bacteri
infect
among
adult
seek
care
acut
exacerb
copd
use
array
method
includ
bacteri
cultur
serolog
rtpcr
assay
respiratori
virus
atyp
bacteria
prospect
studi
conduct
two
consecut
winter
season
took
place
three
universityaffili
hospit
provinc
quebec
canada
patient
recruit
januari
may
first
winter
januari
may
second
winter
particip
copd
patient
age
year
consult
admit
particip
hospit
acut
exacerb
ill
day
onset
symptom
copd
patient
defin
baselin
forc
expiratori
volum
per
second
fev
less
predict
valu
chronic
bronchiti
cough
sputum
monthsyear
consecut
year
acut
exacerb
defin
increas
respiratori
symptom
dyspnea
cough
sputum
requir
unschedul
medic
visit
patient
bronchiectasi
cystic
fibrosi
present
exacerb
asthma
exclud
second
year
control
group
stabl
copd
patient
consult
regular
followup
also
includ
patient
without
pair
sera
also
exclud
obtain
inform
consent
research
nurs
collect
clinic
data
date
onset
type
symptom
previou
medic
condit
current
medic
medic
investig
chest
xray
oxygen
satur
fev
standard
questionnair
nasopharyng
aspir
npa
blood
test
acut
phase
sera
collect
well
noninduc
sputum
second
blood
sampl
convalesc
phase
sera
drawn
day
later
addit
data
collect
evolut
diseas
data
hospit
stay
admiss
intens
care
unit
extract
medic
chart
discharg
npa
specimen
test
presenc
respiratori
virus
influenza
b
rsv
human
metapneumoviru
hmpv
parainfluenza
piv
adenovirus
rhinovirus
coronavirus
atyp
bacteria
legionella
pneumophila
chlamydophila
pneumonia
mycoplasma
pneumonia
use
pcr
assay
npa
specimen
first
test
use
multiplex
realtim
rtpcr
assay
influenza
b
rsv
hmpv
multiplex
assay
describ
detail
elsewher
lower
limit
detect
copi
influenza
b
copi
rsv
copi
hmpv
use
methodolog
specimen
also
test
second
multiplex
rtpcr
assay
presenc
rhinovirus
adenovirus
amplifi
gene
lower
limit
detect
second
multiplex
pcr
follow
hemagglutininneuraminidas
copi
nucleocapsid
copi
rhinovirus
noncod
region
copi
adenovirus
hexon
copi
third
rtpcr
assay
detect
presenc
coronavirus
nl
individu
assay
use
test
specimen
atyp
bacteria
ie
pneumonia
c
pneumonia
l
pneumophila
acut
convalesc
phase
sera
test
presenc
total
antibodi
direct
influenza
b
hrsv
hmpv
piv
adenovirus
l
pneumophila
c
pneumonia
pneumonia
complement
fixat
test
wherea
elisa
test
use
hmpv
evid
acut
infect
defin
increas
antibodi
titer
seroconvers
acut
convalesc
sera
noninduc
sputum
cultur
blood
chocol
agar
plate
bacteri
pathogen
identifi
use
microscan
system
baxter
healthcar
corpor
west
sacramento
california
differ
clinic
present
delay
onset
consult
length
stay
evalu
test
rsv
influenza
infect
b
viral
nonvir
exacerb
tabl
sixtytwo
patient
year
year
old
year
old
overal
patient
underli
cardiovascular
diseas
diabet
case
vaccin
influenza
nearli
patient
histori
tobacco
current
smoke
sever
copd
fev
predict
valu
present
wherea
moder
copd
fev
predict
valu
found
cours
exacerb
treat
outpati
patient
hospit
admit
intens
care
unit
among
patient
evid
viral
infect
tabl
influenza
rsv
hmpv
rhinovirus
among
patient
viral
infect
influenza
rsv
one
patient
mix
viral
infect
influenza
coronaviru
patient
influenza
receiv
influenza
vaccin
exclud
coronaviru
rhinoviru
infect
serolog
test
perform
viral
infect
identifi
rtpcr
serolog
method
among
rsv
infect
patient
posit
serolog
rtpcr
posit
pcr
posit
serolog
one
patient
pneumonia
detect
pcr
serolog
noninduc
sputum
avail
patient
bacteria
identifi
cultur
tabl
frequent
bacteria
isol
staphylococcu
aureu
patient
pseudomona
aeruginosa
haemophilu
influenza
moraxella
catarrhali
stenotrophomona
maltophilia
streptococcu
pneumonia
eight
patient
infect
microorgan
patient
among
patient
viral
infect
result
sputum
cultur
patient
also
bacteria
sputum
viral
bacteri
mix
infect
found
frequent
patient
sever
copd
defin
fev
predict
valu
less
sever
diseas
second
season
patient
stabl
copd
test
viral
infect
one
posit
compar
patient
aecopd
p
patient
serolog
evid
parainfluenza
infect
posit
rtpcr
rhinoviru
mani
studi
attempt
measur
burden
viral
bacteri
infect
patient
aecopd
search
type
pathogen
sampl
patient
admit
aecopd
evid
respiratori
viral
infect
support
idea
import
aecopd
result
slightli
higher
previous
report
studi
reli
cultur
serolog
identif
respiratori
pathogen
howev
agreement
report
use
nucleic
acid
detect
method
rtpcr
observ
preval
viral
respiratori
infect
aecopd
patient
similar
previous
report
distribut
type
respiratori
virus
differ
influenza
rsv
frequent
found
virus
almost
equal
contributor
aecopd
result
line
previou
studi
found
rhi
total
number
patient
novirus
case
viral
exacerb
much
less
previous
observ
reason
lower
detect
rate
rhinovirus
may
includ
low
sensit
multiplex
rtpcr
assay
pathogen
copi
differ
epidemiolog
season
select
popul
patient
hospit
pathogen
bacteria
found
sputum
patient
aecopd
proport
consist
report
explain
clinic
trial
found
antibiot
clinic
improv
patient
aecopd
frequent
identifi
pathogen
aureu
p
aeruginosa
soler
et
al
found
sever
copd
case
infect
influenza
rsv
also
coinfect
bacteri
pathogen
find
higher
frequenc
mix
infect
patient
sever
diseas
may
reflect
small
number
patient
sever
copd
influenza
rsv
infect
studi
bacteri
analysi
sputum
conduct
patient
abl
submit
adequ
sampl
failur
rate
obtain
valid
sputum
sampl
observ
studi
consist
report
litteratur
patient
sputum
sampl
like
viral
infect
sever
diseas
believ
result
affect
even
sputum
cultur
avail
patient
methodolog
limit
may
led
bia
estim
true
impact
respiratori
virus
aecopd
patient
despit
exclus
patient
consult
day
diseas
onset
viral
shed
adult
may
last
shorter
may
miss
viral
case
also
seek
virus
associ
respiratori
tract
infect
parainfluenza
enterovirus
may
explain
fact
viru
bacteria
found
patient
sputum
season
also
differ
epidemiolog
data
obtain
provinc
refer
laboratori
show
moder
high
respiratori
viru
activ
studi
year
increas
sensit
rtpcr
come
inabl
distinguish
acut
infect
prolong
shed
neither
detect
viru
pcr
seroconvers
mean
unequivoc
virus
caus
actual
diseas
recent
research
identifi
rsv
larg
percentag
stabl
copd
patient
rais
possibl
persist
lowgrad
rsv
infect
despit
fact
rsv
detect
associ
elev
marker
inflamm
rapid
declin
lung
function
suggest
role
pathogenesi
evolut
diseas
presenc
high
proport
rsvinfect
stabl
cpod
patient
rais
possibl
colon
could
detect
patient
group
control
small
limit
one
season
found
none
rsv
infect
conclus
viral
infect
frequent
patient
aecopd
rsv
appear
frequent
influenza
patient
bacteri
pathogen
frequent
among
virusinfect
patient
associ
sever
diseas
influenza
detect
aecopd
hospit
test
viru
epidem
period
consid
along
need
antivir
therapi
gaston
de
serr
receiv
research
grant
gsk
sanofi
pasteur
lampron
jacqu
la
forg
paid
lectur
contribut
advisori
board
bayer
abbott
aventi
pasteur
isabel
rouleau
compet
interest
jean
bourbeau
person
financi
relationship
commerci
interest
relev
studi
disclos
past
year
karl
weiss
receiv
research
grant
abbott
bayer
gsk
pfizer
therav
optim
wyeth
barret
current
employ
sanofi
pasteur
guy
boivin
receiv
research
grant
medimmun
studi
rsv
epidemiolog
